US FDA’s Vaccine Advisory Committee Roster Tweaked For Moderna Review

 
• By Derrick Gingery

After the various turnovers, the panel will be one person smaller, and while the agenda includes familiar topics, including maintaining placebo controls after a vaccine is available, the presentation order will be different.

It's not quite musical chairs, but the advisory committee for Moderna's COVID-19 vaccine review will differ from the previous meeting on the Pfizer/BioNTech candidate. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers